Shire plc, SHPG is in the exchange NASDAQ and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in Ireland, Shire plc, SHPG has a market cap of 58743.2. Since its IPO date on the 3/25/1998, Shire plc, SHPG performance year to date is -2.44%. Today Shire plc, SHPG has gained 0.94%, with a current price of 201.05.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 20.50%. The management of the company have seen the company have a payout ratio of 10.00%. Return of assets are at 7.00%, with return on investment at 12.00%.
In terms of debt levels and profit levels, Shire plc, SHPG is seeing a long-term debt/equity of 0.45. While Total debt/equity is 0.67. With a profit margin of 19.80%, this is combined with a gross margin of 85.10%, and operating margin of 22.40%. Shire plc ability to meet debt levels, with a current ratio of 0.6, while the quick ratio is 0.4.
For the last year Shire plc, SHPG has seen a EPS growth of -59.40%. A performance for the year of -21.09%. The 52-week high is -23.37%, and the 52-week low is 36.79%. The average volume for Shire plc, SHPG is 635221.
With a target price of 240.46, can Shire plc, SHPG reach this target? Looking at the value indicators of Shire plc, SHPG. Shire plc has a P/E of 29.52 and a forward P/E of 13.35. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.79. Shire plc also has a P/S and a P/B of 8.85 and 3.82 respectively. For P/cash, Shire plc has a value of 851.35, while it is *TBA for P/free cash flow.
At the current price of 201.05, Shire plc has a dividend yield of 0.67%. We see a return on equity of 13.50%.
Looking more long-term Shire plc, is projected to get an EPS growth for the next five years of 16.50%. In the short-term an EPS growth of 19.25% in the next year is forecasted. This is after a EPS growth of -59.40% for this year and for the last five years a 16.50% growth has been seen.